Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-042796
Filing Date
2021-06-23
Accepted
2021-06-23 17:35:22
Documents
1
Period of Report
2021-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5517
  Complete submission text file 0001209191-21-042796.txt   6896
Mailing Address 60 WEST 66TH STREET, 26A NEW YORK NY 10023
Business Address
Bishop Hans Edgar (Reporting) CIK: 0001480212 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 211039586

Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations